PIAS1
E3 SUMO-protein ligase PIAS1
Also known as: DDXBP1, GBP, GU/RH-II, PIAS1_HUMAN, ZMIZ3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75925
- Gene
- PIAS1
- Ensembl
- ENSG00000033800
- Chromosome
- 15
- Canonical length
- 651 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the protein inhibitor of activated STAT (PIAS) family. PIAS proteins function as SUMO E3 ligases and play important roles in many cellular processes by mediating the sumoylation of target proteins. This protein plays a central role as a transcriptional coregulator of numerous cellular pathways includign the STAT1 and nuclear factor kappaB pathways. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Canonical amino-acid sequenceUniProt
651 residues, UniProt reviewed canonical sequence.
>O75925|PIAS1
1 MADSAELKQM VMSLRVSELQ VLLGYAGRNK HGRKHELLTK ALHLLKAGCS PAVQMKIKEL
61 YRRRFPQKIM TPADLSIPNV HSSPMPATLS PSTIPQLTYD GHPASSPLLP VSLLGPKHEL
121 ELPHLTSALH PVHPDIKLQK LPFYDLLDEL IKPTSLASDN SQRFRETCFA FALTPQQVQQ
181 ISSSMDISGT KCDFTVQVQL RFCLSETSCP QEDHFPPNLC VKVNTKPCSL PGYLPPTKNG
241 VEPKRPSRPI NITSLVRLST TVPNTIVVSW TAEIGRNYSM AVYLVKQLSS TVLLQRLRAK
301 GIRNPDHSRA LIKEKLTADP DSEIATTSLR VSLLCPLGKM RLTIPCRALT CSHLQCFDAT
361 LYIQMNEKKP TWVCPVCDKK APYEHLIIDG LFMEILKYCT DCDEIQFKED GTWAPMRSKK
421 EVQEVSASYN GVDGCLSSTL EHQVASHHQS SNKNKKVEVI DLTIDSSSDE EEEEPSAKRT
481 CPSLSPTSPL NNKGILSLPH QASPVSRTPS LPAVDTSYIN TSLIQDYRHP FHMTPMPYDL
541 QGLDFFPFLS GDNQHYNTSL LAAAAAAVSD DQDLLHSSRF FPYTSSQMFL DQLSAGGSTS
601 LPTTNGSSSG SNSSLVSSNS LRESHSHTVT NRSSTDTASI FGIIPDIISL DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIAS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- thymus: 23 nTPM
- bone marrow: 22 nTPM
- retina: 20 nTPM
- testis: 19 nTPM
- thyroid gland: 18 nTPM
- ovary: 18 nTPM
Single-cell type
- neutrophils: 1,663 nCPM
- neutrophil progenitors: 1,313 nCPM
- leydig cells: 625 nCPM
- microglia: 555 nCPM
- kupffer cells: 498 nCPM
- esophageal apical cells: 454 nCPM
Immune cell
- neutrophil: 71 nTPM
- eosinophil: 42 nTPM
- basophil: 34 nTPM
- classical monocyte: 31 nTPM
- myeloid DC: 31 nTPM
- total PBMC: 27 nTPM
Brain region
- cerebellum: 36 nTPM
- cerebral cortex: 30 nTPM
- hypothalamus: 29 nTPM
- basal ganglia: 26 nTPM
- white matter: 26 nTPM
- choroid plexus: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIAS1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 124 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on PIAS1 was assayed in.
- breast cancer T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.09
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.72
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via JAK-STAT
- DNA damage response
- fat cell differentiation
- G1/S transition of mitotic cell cycle
- negative regulation of apoptotic process
- negative regulation of transcription by RNA polymerase II
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of protein localization to cell periphery
- positive regulation of protein sumoylation
- positive regulation of smooth muscle cell differentiation
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription initiation by RNA polymerase II
- protein sumoylation
- protein-DNA complex assembly
- regulation of cell population proliferation
- regulation of transcription by RNA polymerase II
- spermatogenesis
- visual learning
Molecular functions
- DNA-binding transcription factor binding
- enzyme binding
- protein domain specific binding
- SUMO ligase activity
- SUMO transferase activity
- transcription cis-regulatory region binding
- transcription coregulator activity
- transcription corepressor activity
- ubiquitin protein ligase binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIAS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIAS1 as an antibody target. Whether an autoantibody or antibody against PIAS1 could matter depends on whether native PIAS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIAS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIAS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...